RESCINDED
October 22, 2021
PAR-21-063 - NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
PAR-21-064 - NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
NOT-DC-21-006 - Notice of Invitation for Applicants to NIDCD PAR-21-063 and PAR-21-064 to Consult with the NCATS Clinical and Translational Science Award (CTSA) Trial Innovation Network (TIN) Prior to Submission
National Institute on Deafness and Other Communication Disorders (NIDCD)
This Notice announces that National Institute on Deafness and Other Communication Disorders (NIDCD) plans to post a previously recorded informational webinar that will provide technical assistance to applicants planning to respond to NOT-DC-21-006 - Notice: Invitation for Applicants to NIDCD PAR-21-063 or PAR-21-064 to Consult with the Clinical and Translational Science Award (CTSA) Trial Innovation Network (TIN) Prior to Submission.
The webinar will be posted on the NIDCD Clinical Studies website no later than October 7, 2021 and will be linked to additional resources helpful in the application process. The posted webinar will explain the goals and objectives of NOT-DC-21-006, provide guidance on resources and services available from the Trial Innovation Network and provide technical assistance in navigating the TIN website and formulating a consultation request. No comments on specific ideas or plans for individual research applications will be provided during the webinar.
Applicants are encouraged to submit questions for FAQ posting via email at any time to Dr. Mary Purucker. Viewing the posted webinar, although encouraged, is optional and is not required for the submission of an application.
Mary Purucker, M.D., Ph. D.
National Institute on Deafness and Other Communication Disorders
Division of Scientific Programs
Telephone: 240-285-8793
Email: puruckerm@mail.nih.gov